What is the Preferred GnRH Analogue for Polycystic Ovary Syndrome Patients Undergoing Controlled Ovarian Hyperstimulation for in Vitro Fertilization?
Overview
Affiliations
In an attempt to evaluate the influence of the GnRH analogue used during controlled ovarian hyperstimulation (COH) on the outcome of IVF cycles of polycystic ovary syndrome (PCOS) patients, we studied 152 IVF cycles. The PCOS patients undergoing COH using the GnRH agonist protocol (n = 50) showed a significantly higher pregnancy rate (36% vs. 19.6%, respectively), compared with the GnRH antagonist protocol (n = 102).
Zhai J, Zhang J, He J, Lv M, Zhang B, Li G J Multidiscip Healthc. 2023; 16:2781-2792.
PMID: 37753342 PMC: 10518358. DOI: 10.2147/JMDH.S432936.
Kadoura S, Alhalabi M, Nattouf A Sci Rep. 2022; 12(1):4456.
PMID: 35292717 PMC: 8924277. DOI: 10.1038/s41598-022-08400-z.
Chen Y, Zhao J, Zhang H Med Sci Monit. 2018; 24:9424-9428.
PMID: 30591703 PMC: 6322365. DOI: 10.12659/MSM.913757.
Lai Q, Xiang W, Li Q, Zhang H, Li Y, Zhu G Front Med. 2017; 12(5):518-524.
PMID: 29260383 DOI: 10.1007/s11684-017-0575-y.
Prajapati K, Desai M, Shah S, Choudhary S, Aggarwal R, Mishra V J Pharmacol Pharmacother. 2017; 8(3):116-121.
PMID: 29081619 PMC: 5642124. DOI: 10.4103/jpp.JPP_43_17.